To corroborate the dysregulation of Fbxo4–Fxr1 axis, both ESCC and melanoma cells were utilised due to the presence of Fbxo4 mutations in these cancers3, 14. This evidence concerns the gene FBXO4 and esophageal squamous cell carcinoma.